HGF, hepatocyte growth factor, 3082

N. diseases: 671; N. variants: 22
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0023903
Disease: Liver neoplasms
Liver neoplasms
0.400 Biomarker group BEFREE HGF chemoattracts more macrophages migrated from surrounding area, regulates the distribution of M2 macrophages and increases hepatoma resistance to sorafenib in a feed-forward manner. 31130723 2019
CUI: C0023903
Disease: Liver neoplasms
Liver neoplasms
0.400 Biomarker group BEFREE In conclusion, nobiletin attenuates HGF-induced HepG2 cells metastasis involving both ERK and PI3K/Akt pathways and are potentially useful as anti-metastatic agents for the treatment of hepatoma. 23537747 2013
CUI: C0023903
Disease: Liver neoplasms
Liver neoplasms
0.400 Biomarker group BEFREE PKC mediates fluctuant ERK-paxillin signaling for hepatocyte growth factor-induced migration of hepatoma cell HepG2. 23524339 2013
CUI: C0023903
Disease: Liver neoplasms
Liver neoplasms
0.400 Biomarker group BEFREE Hepatocyte growth factor (HGF) has an inhibitory effect on human HepG2 hepatoma cell proliferation. 24177224 2013
CUI: C0023903
Disease: Liver neoplasms
Liver neoplasms
0.400 Biomarker group BEFREE Furthermore, the mechanism of thrombocytosis induced by HGF in vitro was analyzed in hepatoma cell line HepG2. 17260004 2007
CUI: C0023903
Disease: Liver neoplasms
Liver neoplasms
0.400 AlteredExpression group LHGDN The clinical value of hepatocyte growth factor and its receptor--c-met for liver cancer patients with hepatectomy. 16627020 2006
CUI: C0023903
Disease: Liver neoplasms
Liver neoplasms
0.400 Biomarker group BEFREE Adenoviral gene transduction of hepatocyte growth factor elicits inhibitory effects for hepatoma. 15942646 2005
CUI: C0023903
Disease: Liver neoplasms
Liver neoplasms
0.400 Biomarker group BEFREE Hepatocyte growth factor enhances protein phosphatase Cdc25A inhibitor compound 5-induced hepatoma cell growth inhibition via Akt-mediated MAPK pathway. 15534860 2005
CUI: C0023903
Disease: Liver neoplasms
Liver neoplasms
0.400 Biomarker group BEFREE The objective of the present study was to characterize the expression of two hepatotrophic growth factor/receptor systems [transforming growth factor-alpha/epidermal growth factor receptor (TGF-alpha/EGFR) and hepatocyte growth factor/c-met receptor (HGF/c-met)], both of which are implicated in the development of human liver tumors. 9815784 1997
CUI: C0023903
Disease: Liver neoplasms
Liver neoplasms
0.400 Therapeutic group CTD_human Transgenic mouse models in carcinogenesis: interaction of c-myc with transforming growth factor alpha and hepatocyte growth factor in hepatocarcinogenesis. 8807143 1996
CUI: C0023903
Disease: Liver neoplasms
Liver neoplasms
0.400 AlteredExpression group BEFREE Expression of hepatocyte growth factor mRNA, and c-met mRNA (hepatocyte growth factor receptor) in human liver tumours. 7989714 1994